Travere Therapeutics

ISIN US89422G1076

 | 

WKN A2QHYP

Market cap (in EUR)
2,730 m
Country
United States
Sector
Healthcare
Dividend yield
0.00%
 

Overview

Description

Travere Therapeutics, Inc. is a biopharmaceutical company. It engages in the identification, development, commercialization, and distribution of therapies to people living with rare diseases. The firm's products include Chenodal, Cholbam, and Thiola. The company was founded by Martin Shkreli on February 7, 2008 and is headquartered in San Diego, CA.
Show more Show less
Healthcare Biopharmaceuticals System-Specific Biopharmaceuticals United States

Financials

Key metrics

Market capitalisation, EUR 2,730 m
EPS, EUR -0.98
P/B ratio 43.3
P/E ratio -
Dividend yield 0.00%

Income statement (2024)

Revenue, EUR 216 m
Net income, EUR -296 m
Profit margin -137.51%

What ETF is Travere Therapeutics in?

There are 23 ETFs which contain Travere Therapeutics. All of these ETFs are listed in the table below. The ETF with the largest weighting of Travere Therapeutics is the L&G Pharma Breakthrough UCITS ETF.
ETF Weight Investment focus Fund size (in m EUR)
JPMorgan BetaBuilders US Small Cap Equity UCITS ETF USD (acc) 0.05%
Equity
United States
Small Cap
 56
UBS MSCI USA Select Factor Mix UCITS ETF hEUR acc 0.01%
Equity
United States
Multi-Factor Strategy
 9
SPDR MSCI All Country World Investable Market UCITS ETF (Acc) 0.00%
Equity
World
 4,171
BNP Paribas Easy MSCI USA Small Cap Min TE UCITS ETF EUR Acc 0.05%
Equity
United States
Small Cap
 47
UBS MSCI USA Select Factor Mix UCITS ETF USD acc 0.01%
Equity
United States
Multi-Factor Strategy
 96
SPDR MSCI World Small Cap UCITS ETF 0.03%
Equity
World
Small Cap
 1,457
Xtrackers Portfolio UCITS ETF 1C 0.00%
Equity
World
Multi-Asset Strategy
 681
L&G Russell 2000 US Small Cap Quality UCITS ETF 0.09%
Equity
United States
Small Cap
 179
Xtrackers Russell 2000 UCITS ETF 1C 0.11%
Equity
United States
Small Cap
 1,942
SPDR MSCI All Country World Investable Market UCITS ETF (Dist) 0.00%
Equity
World
 74
JPMorgan BetaBuilders US Small Cap Equity UCITS ETF USD (dist) 0.05%
Equity
United States
Small Cap
 185
UBS MSCI USA Select Factor Mix UCITS ETF USD dis 0.01%
Equity
United States
Multi-Factor Strategy
 26
UBS MSCI USA Select Factor Mix UCITS ETF hCHF acc 0.01%
Equity
United States
Multi-Factor Strategy
 31
iShares MSCI USA Small Cap ESG Enhanced CTB UCITS ETF USD (Acc) 0.02%
Equity
United States
Small Cap
 1,865
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) 0.25%
Equity
United States
Health Care
Biotech
 45
iShares MSCI World Small Cap UCITS ETF 0.03%
Equity
World
Small Cap
 6,481
iShares Nasdaq US Biotechnology UCITS ETF 0.25%
Equity
United States
Health Care
Biotech
 740
SPDR MSCI USA Small Cap Value Weighted UCITS ETF 0.00%
Equity
United States
Small Cap
 732
SPDR MSCI World Small Cap UCITS ETF USD Unhedged (Dist) 0.03%
Equity
World
Small Cap
 25
iShares MSCI World Small Cap ESG Enhanced CTB UCITS ETF USD (Acc) 0.01%
Equity
World
Small Cap
 195
SPDR Russell 2000 US Small Cap UCITS ETF 0.11%
Equity
United States
Small Cap
 4,102
BNP Paribas Easy MSCI USA Small Cap Min TE UCITS ETF USD Acc 0.05%
Equity
United States
Small Cap
 26
L&G Pharma Breakthrough UCITS ETF 4.04%
Equity
World
Health Care
Innovation
 18
Latest articles
Popular articles
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH.

Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.